Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:8:4399-413.
doi: 10.2147/IJN.S51881. Epub 2013 Nov 15.

Green synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cells

Affiliations

Green synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cells

Sangiliyandi Gurunathan et al. Int J Nanomedicine. 2013.

Abstract

Background: Silver nanoparticles (AgNPs) are an important class of nanomaterial for a wide range of industrial and biomedical applications. AgNPs have been used as antimicrobial and disinfectant agents due their detrimental effect on target cells. The aim of our study was to determine the cytotoxic effects of biologically synthesized AgNPs using hot aqueous extracts of the mycelia of Ganoderma neo-japonicum Imazeki on MDA-MB-231 human breast cancer cells.

Methods: We developed a green method for the synthesis of water-soluble AgNPs by treating silver ions with hot aqueous extract of the mycelia of G. neo-japonicum. The formation of AgNPs was characterized by ultraviolet-visible absorption spectroscopy, X-ray diffraction, dynamic light scattering, and transmission electron microscopy. Furthermore, the toxicity of synthesized AgNPs was evaluated using a series of assays: such as cell viability, lactate dehydrogenase leakage, reactive oxygen species generation, caspase 3, DNA laddering, and terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick-end labeling in human breast cancer cells (MDA-MB-231).

Results: The ultraviolet-visible absorption spectroscopy results showed a strong resonance centered on the surface of AgNPs at 420 nm. The X-ray diffraction analysis confirmed that the synthesized AgNPs were single-crystalline, corresponding with the result of transmission electron microscopy. Treatment of MDA-MB-231 breast cancer cells with various concentrations of AgNPs (1-10 μg/mL) for 24 hours revealed that AgNPs could inhibit cell viability and induce membrane leakage in a dose-dependent manner. Cells exposed to AgNPs showed increased reactive oxygen species and hydroxyl radical production. Furthermore, the apoptotic effects of AgNPs were confirmed by activation of caspase 3 and DNA nuclear fragmentation.

Conclusion: The results indicate that AgNPs possess cytotoxic effects with apoptotic features and suggest that the reactive oxygen species generated by AgNPs have a significant role in apoptosis. The present findings suggest that AgNPs could contribute to the development of a suitable anticancer drug, which may lead to the development of a novel nanomedicine for the treatment of cancers.

Keywords: AgNPs; DNA fragmentation; Ganoderma neo-japonicum; caspase-3 activity; cytotoxicity; human breast cancer cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Synthesis of silver nanoparticles (AgNPs) using Ganoderma neo-japonicum extract. The photo shows containers with samples of AgNO3 (1), G. neo-japonicum mycelia extract (2), AgNO3 with the G. neo-japonicum mycelia extract (3). after exposure for 24 hours the color of the solution turned from colorless to brown, indicating the formation of AgNPs.
Figure 2
Figure 2
The ultraviolet-visible spectra of silver nanoparticles (AgNPs). The absorption spectra of AgNPs exhibited a strong broad peak at 420 nm, and observation of this band was attributed to surface plasmon resonance of the particles.
Figure 3
Figure 3
X-ray diffraction pattern of the silver nanoparticles (AgNPs) derived from Ganoderma neo-japonicum mycelial extract. The diffractions at 38.28° and 44.38° 2θ can be indexed to the (111) and (200) planes of the face-centered cubic AgNPs, respectively. Note: The stars indicate the nonspecific peaks due to biomass residues.
Figure 4
Figure 4
Size-distribution analysis by dynamic light scattering. The particle size-distribution analysis revealed that particle size was about 5 nm. Abbreviations: dnm, diameter; PDI, polydispersity index.
Figure 5
Figure 5
Size and morphology of silver nanoparticle (AgNP) analysis by transmission electron microscopy (TEM). Notes: Several fields were photographed and used to determine the diameter of the NPs. Representative TEM image of AgNPs produced by Ganoderma neo-japonicum mycelial extract. The maximum size of the observed diameter was 5 nm.
Figure 6
Figure 6
Cytotoxic effect of silver nanoparticles (AgNPs) on MDA-MB-231 human breast cancer cells. Cells were treated with AgNPs at various concentrations for 24 hours, and cytotoxicity was determined by the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) method. Notes: The results represent the means of three separate experiments, and error bars represent the standard error of the mean. Treated groups showed statistically significant differences from the control group with Student’s t-test (P<0.05).
Figure 7
Figure 7
Effect of silver nanoparticles (AgNPs) on lactate dehydrogenase activity in MDA-MB-231 human breast cancer cells. Notes: The cells were treated with various concentrations of AgNPs. The effect of AgNPs on lactate dehydrogenase activity was measured by changes in optical densities due to nicotinamide adenine dinucleotide (NAD) reduction that were monitored at 490 nm, using Roche’s cytotoxicity detection lactate dehydrogenase kit. The results represent the means of three separate experiments, and error bars represent the standard error of the mean. Treated groups showed statistically significant differences from the control group with Student’s t-test (P<0.05).
Figure 8
Figure 8
Silver nanoparticles (AgNPs) induce reactive oxygen species (ROS) generation in MDA-MB-231 human breast cancer cells. Relative fluorescence of 2′,7′-dichlorofluorescein was measured using a spectrofluorometer with excitation at 485 nm and emission at 530 nm. Notes: The results represent the means of three separate experiments, and error bars represent the standard error of the mean. Treated groups showed statistically significant differences from the control (CON) group with Student’s t-test (P<0.05). Abbreviations: DOX, doxorubicin; Nac, N-acetyl-L-cysteine.
Figure 9
Figure 9
Silver nanoparticles (AgNPs) induce the activity of caspase 3 in MDA-MB-231 human breast cancer cells. MDA-MB-231 cells were treated with AgNPs, doxorubicin (DOX), and/or a caspase-3 inhibitor (Ac-DEVD-CHO) for 24 hours. Notes: The concentration of the p-nitroaniline released from the substrate was calculated from the absorbance values at 405 nm. The results represent the means of three separate experiments, and error bars represent the standard error of the mean. Treated groups showed statistically significant differences from the control group with Student’s t-test (P<0.05). Abbreviation: CON, control.
Figure 10
Figure 10
Effect of silver nanoparticles (AgNPs) on DNA fragmentation. MDA-MB-231 human breast cancer cells were treated with AgNPs for 24 hours, and DNA fragmentation was analyzed by agarose gel electrophoresis. Notes: Lane M, 1 kB ladder; lane 1, control; lane 2, AgNPs (6 μg/mL); lane 3, doxorubicin (1 μM).
Figure 11
Figure 11
Terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick-end labeling (TUNEL) assay. Fluorescent staining of MDA-MB-231 human breast cancer cells after 24 hours’ treatment with silver nanoparticles (AgNPs; 6 μg/mL) and doxorubicin (DOX; 1 μM) using TUNEL assay. Note: Representative images are shown for apoptotic DNA fragmentation (red staining) and corresponding nuclei (blue staining). Abbreviations: CON, control; DAPI, 4′,6-diamidino-2-phenylindole.

Similar articles

Cited by

References

    1. Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol Lett. 2008;176:1–12. - PubMed
    1. Stensberg MC, Wei Q, McLamore ES, Porterfield DM, Wei A, Sepúlveda MS. Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine (Lond) 2011;6:879–898. - PMC - PubMed
    1. Tian J, Wong KK, Ho CM, et al. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem. 2007;2:129–136. - PubMed
    1. Malik MA, Brien PO, Revaprasadu N. A simple route to the synthesis of core/shell nanoparticles of chalcogenides. Chem Mater. 2002;14:2004–2010.
    1. Thakkar KN, Mhatre SS, Parikh RY. Biological synthesis of metallic nanoparticles. Nanomedicine. 2010;6:257–262. - PubMed

Publication types